Anavex Life Sciences Corp (AVXL) — Financial Flexibility Index
Anavex Life Sciences Corp (AVXL) has a Financial Flexibility Index of -1.76x as of June 2026. Free cash flow of $-13.54 Million (operating CF $-13.54 Million minus capex $0.00) represents -2% of total liabilities ($7.69 Million). Check Anavex Life Sciences Corp (AVXL) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Anavex Life Sciences Corp Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Anavex Life Sciences Corp across 22 annual periods. For the full cash flow conversion analysis, see Anavex Life Sciences Corp operating cash flow efficiency.
Annual Financial Flexibility Index for Anavex Life Sciences Corp (2004–2025)
Year-by-year free cash flow to debt coverage for Anavex Life Sciences Corp. Explore Anavex Life Sciences Corp (AVXL) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.36x | $-39.04 Million | $-39.04 Million | $8.95 Million | ▼ -116.8% |
| 2024 | -2.01x | $-30.81 Million | $-30.81 Million | $15.30 Million | ▲ +9.2% |
| 2023 | -2.22x | $-27.79 Million | $-27.79 Million | $12.53 Million | ▲ +6.6% |
| 2022 | -2.37x | $-24.24 Million | $-24.24 Million | $10.21 Million | ▲ +15.7% |
| 2021 | -2.81x | $-30.38 Million | $-30.38 Million | $10.80 Million | ▲ +3.4% |
| 2020 | -2.91x | $-21.29 Million | $-21.29 Million | $7.31 Million | ▲ +20.7% |
| 2019 | -3.68x | $-18.53 Million | $-18.53 Million | $5.04 Million | ▼ -13.5% |
| 2018 | -3.24x | $-12.58 Million | $-12.58 Million | $3.88 Million | ▼ -28.8% |
| 2017 | -2.52x | $-9.02 Million | $-9.02 Million | $3.58 Million | ▲ +13.1% |
| 2016 | -2.89x | $-9.23 Million | $-9.24 Million | $3.19 Million | ▼ -82.2% |
| 2015 | -1.59x | $-4.23 Million | $-4.23 Million | $2.66 Million | ▼ -328.2% |
| 2014 | -0.37x | $-2.66 Million | $-2.66 Million | $7.16 Million | ▼ -36.3% |
| 2013 | -0.27x | $-777.57K | $-777.57K | $2.86 Million | ▲ +53.6% |
| 2012 | -0.59x | $-1.69 Million | $-1.69 Million | $2.89 Million | ▲ +79.3% |
| 2011 | -2.83x | $-3.80 Million | $-3.80 Million | $1.35 Million | ▼ -102.5% |
| 2010 | -1.40x | $-4.59 Million | $-4.59 Million | $3.29 Million | ▼ -113.1% |
| 2009 | -0.65x | $-2.79 Million | $-2.79 Million | $4.27 Million | ▲ +39.1% |
| 2008 | -1.08x | $-2.47 Million | $-2.47 Million | $2.30 Million | ▼ -52.9% |
| 2007 | -0.70x | $-325.25K | $-325.25K | $462.53K | ▲ +39.3% |
| 2006 | -1.16x | $-32.43K | $-32.43K | $28.01K | ▲ +48.8% |
| 2005 | -2.26x | $-61.07K | $-61.07K | $27.00K | ▲ +52.3% |
| 2004 | -4.75x | $-11.89K | $-11.89K | $2.50K | — |